News

Fully human antibodies offer distinct advantages in antibody drug development. They trigger minimal immune response (immunogenicity) in patients, leading to improved safety and tolerance compared to traditional antibody therapies. This approach also focuses on identifying high-affinity and highly specific antibodies, ensuring they effectively target the desired molecules. Understanding Fully Human Antibodies  Monoclonal antibodies (mAbs) are […]

Cancer immunotherapy has emerged as a transformative approach in oncology, with immune checkpoint inhibitors (ICIs) at the forefront. ICIs work by blocking regulatory pathways in T cells that cancer cells exploit to evade immune detection. Mechanisms of Immune Checkpoint Inhibitors  Immune checkpoints are regulatory pathways that maintain self-tolerance and modulate the duration and amplitude of

Chinese hamster ovary (CHO) cells have emerged as the predominant expression system for producing recombinant antibodies due to their ability to perform complex post-translational modifications and their suitability for large-scale production. Despite their widespread use, achieving high-level expression and maintaining the quality of recombinant antibodies in CHO cells involves overcoming several technical challenges.  Optimization of

In the complex landscape of drug discovery and development, preclinical studies are instrumental in evaluating the safety, efficacy, and biological activity of potential therapeutic agents before they reach clinical trials. A critical component of these studies is the use of biologics, particularly Research-Use-Only (RUO) biologics. While RUO biologics are not intended for clinical use, they

Bispecific antibodies (BsAbs) offer unparalleled versatility and precision in targeting multiple antigens or epitopes. As the biopharmaceutical industry continues to explore the therapeutic potential of these engineered molecules, their role in in vivo studies is expanding rapidly. This transformation is not only enhancing the understanding of complex biological processes but also driving innovation in drug

A review by researchers from the University of Virginia highlights the role of antibody-dependent cellular phagocytosis (ADCP) in cancer immunotherapy. Unconjugated monoclonal antibodies (mAbs) have significantly impacted cancer treatment by targeting specific antigens on malignant cells. Widely used mAbs, such as anti-CD20 (rituximab, obinutuzumab), anti-HER2 (trastuzumab), and anti-CD38 (daratumumab), use ADCP to target and remove

The field of biotherapeutics has seen rapid advancements with antibodies and antibody-like formats emerging as a major class of therapeutic proteins. For scientists and researchers in biotech, understanding the structural and dynamic characteristics of antibodies is crucial. These insights inform the engineering of more effective therapeutic antibodies and vaccines.   Antibodies are Y-shaped molecules composed of

Antibody-Drug Conjugates (ADCs) are a breakthrough in oncology, integrating the targeting precision of monoclonal antibodies (mAbs) with the potent cytotoxic effects of traditional chemotherapy. Their design aims to improve cancer treatment by ensuring that powerful anti-cancer drugs reach and destroy tumor cells while minimizing damage to healthy tissues. This article provides a detailed exploration of

Combination therapies and synergistic approaches refer to the use of multiple treatments or interventions together to enhance their effectiveness in addressing a disease. This approach is employed in various fields of medicine, including cancer, infectious diseases, and mental health.   Monoclonal antibody (mAb) therapeutics have been successfully developed and commercialized for various indications, including the neutralization

Antibodies are indispensable tools in both research and clinical diagnostics, serving as highly specific detectors of antigens – molecules capable of eliciting an immune response. Custom antibody development refers to the generation of antibodies against a specific antigen of interest, which may not be available on a catalog. This approach allows researchers to study novel